NCT03813433

Brief Summary

the objective of this study is to evaluate post operative pain after using Endosequence versus Mineral Trioxide Aggregate as coronal plug material in revascularization of non vital immature anterior teeth

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 23, 2019

Completed
4.4 years until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

July 19, 2022

Status Verified

September 1, 2021

Enrollment Period

5 months

First QC Date

January 14, 2019

Last Update Submit

July 18, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • discoloration

    Asking patient question (Binary:present or absent)

    1 month

  • discoloration

    Asking patient question (Binary:present or absent)

    3 months

  • dicoloration

    Asking patient question (Binary:present or absent)

    6 months

  • discoloration

    Asking patient question (Binary:present or absent)

    9 months

  • discoloration

    Asking patient question (Binary:present or absent)

    12months

Secondary Outcomes (6)

  • post operative pain

    1,3, 6, 9 and 12 months

  • color stability

    1,3, 6, 9 and 12 months

  • Pain on percussion

    1,3, 6, 9 and 12 months

  • Swelling

    1,3, 6, 9 and 12 months

  • Sinus or fistula

    1,3, 6, 9 and 12 months

  • +1 more secondary outcomes

Study Arms (2)

Enosequence

EXPERIMENTAL

3-4 mm of Endosequence will be applied over the blood clot in group I. Material will be packed using condenser with light pressure. Periapical radiograph will be taken to ensure coronal seal in the second visit of revascularization

Other: Revascularization

Mineral Trioxide Aggregate

ACTIVE COMPARATOR

3-4 mm of Mineral Trioxide Aggregate will be applied over the blood clot in group I. Material will be packed using condenser with light pressure. Periapical radiograph will be taken to ensure coronal seal in the second visit of revascularization

Other: Revascularization

Interventions

a procedure used to regenerate pulp dentin complex that restores the functional properties of this immature anterior teeth, prevent and resolves apical periodontitis

Also known as: pulp regeneration
EnosequenceMineral Trioxide Aggregate

Eligibility Criteria

Age8 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age of patient range from 8-14 y.
  • Patients are free from any systemic diseases that may hinder the normal healing process.
  • Non vital permanent anterior teeth with open apex.
  • Pulp space not needed for post and core for final restoration.
  • Compliant patient/parent.

You may not qualify if:

  • Patients having allergy to medicaments and antibiotics necessary to complete the procedure.
  • Tooth with vital pulp or complete root formation.
  • Teeth with internal or external root resorption.
  • Un-cooperative patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Pulp Necrosis

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisstant lecturer

Study Record Dates

First Submitted

January 14, 2019

First Posted

January 23, 2019

Study Start

June 1, 2023

Primary Completion

November 1, 2023

Study Completion

November 1, 2024

Last Updated

July 19, 2022

Record last verified: 2021-09